Literature DB >> 8393114

Synthesis and antiherpes virus activity of 1,5-anhydrohexitol nucleosides.

I Verheggen1, A Van Aerschot, S Toppet, R Snoeck, G Janssen, J Balzarini, E De Clercq, P Herdewijn.   

Abstract

The synthesis of 1,5-anhydrohexitol nucleosides is described. These nucleoside analogues were obtained by alkylation of the heterocyclic bases with the tosylate 10 or by alkylation of the bases with the alcohol 12 under Mitsunobu conditions. The compounds were evaluated for antiviral and cytostatic activity. Highly selective activity against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) was noted for 1,5-anhydro-2,3-dideoxy-2-(5-iodouracil-1-yl)-D-arabino-hexitol 4b at a concentration of 0.07 microgram/mL. This activity must be dependent on a specific phosphorylation by the virus-encoded thymidine kinase (TK), since compound 4b was inactive against TK-deficient mutants of HSV-1. The corresponding cytosine 4c and guanine 4e analogues showed activity against HSV-1, HSV-2, and other herpes viruses (i.e. cytomegalovirus, varicella-zoster virus) at concentrations well below the cytotoxicity threshold (2 and 20 micrograms/mL, respectively). At these concentrations, compounds 4c and 4e proved also inhibitory to the growth of human T-cells (i.e. MT-4, CEM, MOLT-4).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393114     DOI: 10.1021/jm00066a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.

Authors:  E Nandanan; E Camaioni; S Y Jang; Y C Kim; G Cristalli; P Herdewijn; J A Secrist; K N Tiwari; A Mohanram; T K Harden; J L Boyer; K A Jacobson
Journal:  J Med Chem       Date:  1999-05-06       Impact factor: 7.446

2.  Highly stable hexitol based XNA aptamers targeting the vascular endothelial growth factor.

Authors:  Elena Eremeeva; Antonios Fikatas; Lia Margamuljana; Mikhail Abramov; Dominique Schols; Elisabetta Groaz; Piet Herdewijn
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

3.  Synthesis, improved antisense activity and structural rationale for the divergent RNA affinities of 3'-fluoro hexitol nucleic acid (FHNA and Ara-FHNA) modified oligonucleotides.

Authors:  Martin Egli; Pradeep S Pallan; Charles R Allerson; Thazha P Prakash; Andres Berdeja; Jinghua Yu; Sam Lee; Andrew Watt; Hans Gaus; Balkrishen Bhat; Eric E Swayze; Punit P Seth
Journal:  J Am Chem Soc       Date:  2011-09-22       Impact factor: 15.419

4.  Hepatic RNA Interference: Delivery by Synthetic Vectors.

Authors:  Matthew Haynes; Leaf Huang
Journal:  Drug Deliv Transl Res       Date:  2014-02-01       Impact factor: 4.617

5.  Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.

Authors:  E Nandanan; S Y Jang; S Moro; H O Kim; M A Siddiqui; P Russ; V E Marquez; R Busson; P Herdewijn; T K Harden; J L Boyer; K A Jacobson
Journal:  J Med Chem       Date:  2000-03-09       Impact factor: 8.039

6.  Utility of 2-thioxo-pyrido[2,3-d]pyrimidinone in synthesis of pyridopyrimido[2,1-b][1,3,5]-thiadiazinones and pyridopyrimido[2,1-b][1,3]thiazinones as antimicrobial agents.

Authors:  Yasser H Zaki; Sobhi M Gomha; Amany M G Mohamed
Journal:  Chem Cent J       Date:  2017-06-20       Impact factor: 4.215

7.  Isoguanine and 5-methyl-isocytosine bases, in vitro and in vivo.

Authors:  Omprakash Bande; Rania Abu El Asrar; Darren Braddick; Shrinivas Dumbre; Valérie Pezo; Guy Schepers; Vitor B Pinheiro; Eveline Lescrinier; Philipp Holliger; Philippe Marlière; Piet Herdewijn
Journal:  Chemistry       Date:  2015-02-13       Impact factor: 5.236

8.  Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4- and -2-keto-beta-d-glucopyranosyl derivatives of N(4)-benzoyl cytosine.

Authors:  Stella Manta; Evangelia Tsoukala; Niki Tzioumaki; Ales Goropevsek; Ravi Teja Pamulapati; Avrelija Cencic; Jan Balzarini; Dimitri Komiotis
Journal:  Eur J Med Chem       Date:  2009-01-29       Impact factor: 6.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.